当前位置:首页 - 行情中心 - 太龙药业(600222) - 财务分析 - 资产负债表

太龙药业

(600222)

  

流通市值:29.42亿  总市值:30.19亿
流通股本:5.59亿   总股本:5.74亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金196,666,015.69181,546,019.58196,150,648.49248,462,111.96
应收票据及应收账款882,806,520.78773,316,447.59812,508,890.55921,781,428.3
其中:应收票据143,169,278.9869,013,201.9585,157,676.73177,045,846.31
应收账款739,637,241.8704,303,245.64727,351,213.82744,735,581.99
预付款项75,306,846.45100,259,794.4697,819,119.3105,257,366.47
其他应收款合计40,231,703.5365,996,043.4862,890,760.2171,808,764.3
存货455,499,605.26452,156,387.32455,475,510.44433,230,308.3
合同资产172,910,820.17183,635,697.03163,776,408.3155,826,229.65
其他流动资产16,352,517.1617,240,447.610,240,266.9916,299,645.73
流动资产平衡项目0000
流动资产合计1,993,073,631.391,836,729,817.061,863,188,037.51,982,901,387.93
非流动资产:
长期股权投资140,632,574.3156,023,369.6757,795,830.0558,583,919.7
其他权益工具投资348,276,852.24290,038,269.07314,545,050.55376,661,607.55
其他非流动金融资产31,473,641.6697,133,063.2696,253,235.0684,455,474.45
投资性房地产2,619,160.92,646,502.362,673,843.822,701,185.28
固定资产469,318,933.87456,465,198.29463,101,783.93470,313,001.96
在建工程28,898,826.8136,011,459.6332,162,813.0531,785,326.81
使用权资产31,433,894.6135,521,717.7843,321,145.4435,813,504.56
无形资产52,502,812.4153,815,173.0454,070,384.0446,921,080.25
开发支出24,693,870.4928,657,773.323,260,226.7129,580,663.17
商誉286,492,789.75286,492,789.75286,492,789.75286,492,789.75
长期待摊费用25,114,234.8225,133,665.7826,054,248.7226,780,156.35
递延所得税资产94,235,226.2881,037,003.5781,664,526.4590,351,762.5
其他非流动资产48,088,475.6753,617,262.6450,783,186.6949,170,786.69
非流动资产平衡项目0000
非流动资产合计1,583,781,293.821,502,593,248.141,532,179,064.261,589,611,259.02
资产平衡项目0000
资产总计3,576,854,925.213,339,323,065.23,395,367,101.763,572,512,646.95
流动负债:
短期借款381,838,293.41406,818,739.92454,844,017.5452,836,130.56
应付票据及应付账款470,286,100.87456,390,804.24534,595,915.67565,197,886.97
其中:应付票据40,000,00053,570,00093,570,000110,000,000
应付账款430,286,100.87402,820,804.24441,025,915.67455,197,886.97
合同负债11,623,980.923,916,042.8919,459,993.9224,716,025.04
应付职工薪酬17,416,754.8910,408,296.139,104,608.479,646,189.85
应交税费11,018,783.6410,237,345.939,514,432.4432,966,650.8
其他应付款合计627,336,038.21589,447,218.5546,650,713.12628,386,537.28
一年内到期的非流动负债125,108,328.86219,381,712.79220,313,814.83189,469,734.89
其他流动负债5,520,050.944,753,955.034,185,721.143,953,346.57
流动负债平衡项目0000
流动负债合计1,650,148,331.721,721,354,115.431,798,669,217.091,907,172,501.96
非流动负债:
长期借款183,800,0006,800,0006,800,0006,800,000
租赁负债19,285,549.7126,092,983.935,599,167.3137,240,357.84
长期应付款70,000,00080,000,00080,000,000-
预计负债1,615,0001,615,0001,615,0001,615,000
递延收益3,259,183.382,436,033.372,502,883.361,669,733.35
递延所得税负债25,358,343.389,053,622.6712,211,851.6621,424,707.99
非流动负债平衡项目0000
非流动负债合计303,318,076.47125,997,639.94138,728,902.3368,749,799.18
负债平衡项目0000
负债合计1,953,466,408.191,847,351,755.371,937,398,119.421,975,922,301.14
所有者权益(或股东权益):
实收资本(或股本)573,886,283573,886,283573,886,283573,886,283
资本公积675,173,764.23675,174,028.61675,174,028.61675,174,028.61
减:库存股79,724,005.7579,724,005.7579,724,005.7540,310,593.37
其他综合收益128,145,365.9561,033,473.6350,350,384.2991,938,770.97
盈余公积50,907,095.650,907,095.650,907,095.650,907,095.6
未分配利润230,105,075.57169,683,600.07148,278,155.08201,783,788.37
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计1,578,493,578.61,450,960,475.161,418,871,940.831,553,379,373.18
少数股东权益44,894,938.4241,010,834.6739,097,041.5143,210,972.63
股东权益平衡项目0000
股东权益合计1,623,388,517.021,491,971,309.831,457,968,982.341,596,590,345.81
负债和股东权益合计3,576,854,925.213,339,323,065.23,395,367,101.763,572,512,646.95
公告日期2024-03-282023-10-272023-08-192023-04-29
审计意见(境内)标准无保留意见
TOP↑